KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Operating Expenses (2016 - 2025)

Idexx Laboratories has reported Operating Expenses over the past 17 years, most recently at $342.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $342.5 million for Q4 2025, up 10.85% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 3.91% YoY), and the annual figure for FY2025 was $1.3 billion, up 3.91%.
  • Operating Expenses for Q4 2025 was $342.5 million at Idexx Laboratories, up from $328.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for IDXX hit a ceiling of $355.4 million in Q2 2024 and a floor of $108.3 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $137.9 million (2023), compared with a mean of $206.4 million.
  • Biggest five-year swings in Operating Expenses: plummeted 33.48% in 2023 and later surged 160.96% in 2024.
  • Idexx Laboratories' Operating Expenses stood at $128.8 million in 2021, then fell by 1.79% to $126.5 million in 2022, then rose by 9.78% to $138.8 million in 2023, then skyrocketed by 122.55% to $309.0 million in 2024, then grew by 10.85% to $342.5 million in 2025.
  • The last three reported values for Operating Expenses were $342.5 million (Q4 2025), $328.5 million (Q3 2025), and $321.7 million (Q2 2025) per Business Quant data.